Runx3 is associated with the development and progression of gastric cancer and silencing of Runx3 in gastric cancer cells affects the expression of important genes involved in the metastatic process, including cell adhesion, proliferation and apoptosis; such silencing may promote peritoneal metastasis. Here, RUNX3 is linked to gastric cancer.